Andrew Doyle
Founder at IR Scientific, Inc.
Network origin in Andrew Doyle first degree
Entity | Entity type | Industry | |
---|---|---|---|
IR Scientific, Inc.
IR Scientific, Inc. Medical SpecialtiesHealth Technology IR Scientific, Inc. engages in the development of cosmetic and preventive oral health products and commercialize ion release materials. The company was founded by Andrew Doyle and Daniel Boyd in 2018 and is headquartered in Halifax, Canada.
4
| Holding Company | Medical Specialties | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew Doyle via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
HSBC HOLDINGS PLC | Major Banks | Corporate Officer/Principal | |
University of Oxford | College/University | Graduate Degree | |
INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A. | Airlines | Director/Board Member | |
Pancreatic Cancer UK
Pancreatic Cancer UK Miscellaneous Commercial ServicesCommercial Services Pancreatic Cancer UK is a UK-based charity that focuses on providing specialist support to those affected by pancreatic cancer. The British company offers a support line that can be reached at no cost, and invest in research to drive awareness and change. Diana Jupp has been the CEO of the non-profit company since 2017. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Investment Banks/Brokers | Corporate Officer/Principal | |
Kleinwort Benson Ltd. (New York) | Corporate Officer/Principal | ||
ABK Biomedical, Inc.
ABK Biomedical, Inc. BiotechnologyHealth Technology ABK Biomedical, Inc. develops embolotherapeutic products for the treatment of uterine fibroids. It engages in the development, production and sale of embolic agents and peripheral vascular delivery devices. The company was founded by Bob Abraham, Daniel Boyd and Sharon Kehoe in 2012 and is headquartered in Halifax, Canada. | Biotechnology | Founder |
Statistics
International
United Kingdom | 7 |
Hong Kong | 2 |
United States | 2 |
Canada | 2 |
Sectoral
Finance | 5 |
Consumer Services | 2 |
Transportation | 2 |
Commercial Services | 2 |
Health Technology | 2 |
Operational
Corporate Officer/Principal | 7 |
Director/Board Member | 4 |
Founder | 3 |
Graduate Degree | 1 |
President | 1 |
Most connected contacts
Insiders | |
---|---|
Robin Phillips | 9 |
Daniel Boyd | 2 |
Ali Riaz | 1 |
Peter Hickey | 1 |
- Stock Market
- Insiders
- Andrew Doyle
- Company connections